Shukra Pharmaceuticals Ltd Share Price

48.00

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 10-Sep-2018 14-Aug-2018 - -
AGM 10/09/2018 The Company hereby submit the outcome of the Meeting of the Board of Director held on today i.e 14th August, 2018 at 4:00 p.m. and concluded on 6:30 p.m. 1) Considered, adopted and approved Unaudited Financial Results for the quarter ended on 30th June, 2018. 2) The Annual General Meeting will be held on Monday, 10th September, 2018 at 11:00 a.m. at the registered office of the company. 3) The Register of Members & Share Transfer Books of the Company will remain closed from 04th September, 2018 to 10th September, 2018 (both days inclusive) for the purpose of AGM of the Company. 4) Approval and adoption of Secretarial Audit Report. 5) Approval and adoption of Directors Report for the year ended March 31, 2018. 6) Approval and adoption of notice for AGM. 7) Appointment of Mrs. Rupal Patel, Practicing Company Secretary as Scrutinizer for the process of Remote E-voting as well as voting at the AGM. 8) Approval for authority for incorporation of Subsidiary of the company The company has submitted notice of Annual General Meeting scheduled to be held on 10th September, 2018. (As Per BSE Announcement Dated On 18/08/2018) This is to inform you that the Register of Members and the Share Transfer Books of the Company will remain closed from 04th September, 2018 TO 10th September 2018 (both days inclusive) for the purpose of Annual General Meeting (AGM) scheduled to be held on 10th September, 2018 and declaration of Dividend for the FY 2017-18. (As Per BSE Announcement Dated On 27/08/2018) we hereby submit the following outcome of the Annual General Meeting of the Members held today i.e. at 10th September, 2018 at 11:00 a.m. and concluded on 12.30 p.m.:- 1. Adoption and approval of the audited balance sheet as 31st March 2018 and profit & loss account of the company for the year ended on 31st March, 2018 and the Report of the Directors and Auditors. 2. Declaration of dividend @ of 5% on Equity Shares of the Company. 3. Reappointment of Mr. Sujay Mehta, as Director of the Company, who retires by rotation and being eligible offers himself for reappointment. 4. Ratification of appointment of Auditor M/s. B. J. Trivedi & Associates., Chartered Accountants, Ahmedabad who were appointed in the Annual General Meeting in the year 2016 for a block of 5 year until the conclusion of the Annual General Meeting to be held in 2021 and fix his remuneration. (As Per BSE Announcement Dated on 10.09.2018) Shukra Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated On 12/09/2018)